CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project focuses on improving treatment strategies for non-small cell lung cancer (NSCLC) through a new technology called Radiomics. This approach utilizes imaging biomarkers to provide better patient stratification and personalized treatment options.
Lung cancer is the most common cause of death from cancer worldwide with 1.59 million deaths annually.
It also places the highest economic burden of all cancers on the EU with EUR 18.8 billion.
Non-small cell lung cancer (NSCLC) comprises 85% of all lung cancer cases.
The current clinical routine to guide treatment for NSCLC patients is primarily based on the TNM staging system founded in 1958, mainly to look at surgical operability.
However, TNM-based evaluation, nor doctors prediction do not p…
PT THERAGNOSTIC BV
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
